Evening versus morning dosing regimen drug therapy for chronic kidney disease patients with hypertension in blood pressure patterns: a systematic review and meta-analysis

Management of hypertension in chronic kidney disease

(2015) Raymond R. Townsend et al.   Nature Reviews Nephrology

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Administration-Time-Dependent Effects of Hypertension Treatment on Ambulatory Blood Pressure in Patients With Chronic Kidney Disease

(2012) Juan J. Crespo et al.   CHRONOBIOLOGY INTERNATIONAL

A Trial of 2 Strategies to Reduce Nocturnal Blood Pressure in Blacks With Chronic Kidney Disease

(2012) Mahboob Rahman et al.   HYPERTENSION

Analysis of Recent Papers in Hypertension

(2012) Jan N. Basile et al.   Journal of Clinical Hypertension

Effect of Valsartan With Bedtime Dosing on Chronic Kidney Disease Patients With Nondipping Blood Pressure Pattern

(2012) Cheng Wang et al.   Journal of Clinical Hypertension

Bedtime Dosing of Antihypertensive Medications Reduces Cardiovascular Risk in CKD

(2011) R. C. Hermida et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Chronic kidney disease

(2011) Andrew S Levey et al.   LANCET

Administration–time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension

(2010) Michael H. Smolensky et al.   BLOOD PRESSURE MONITORING

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

(2009) Alessandro Liberati et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

World Kidney Day: hypertension and chronic kidney disease

(2009) E Ritz et al.   LANCET

Disparate Estimates of Hypertension Control From Ambulatory and Clinic Blood Pressure Measurements in Hypertensive Kidney Disease

(2008) Velvie Pogue et al.   HYPERTENSION